-
1
-
-
62649155943
-
A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals
-
Browning B.L., Browning S.R. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. American Journal of Human Genetics 2009, 84:210-223.
-
(2009)
American Journal of Human Genetics
, vol.84
, pp. 210-223
-
-
Browning, B.L.1
Browning, S.R.2
-
2
-
-
84862329701
-
Non-invasive prenatal diagnosis of single-gene disorders from maternal blood
-
Bustamante-Aragonés A., et al. Non-invasive prenatal diagnosis of single-gene disorders from maternal blood. Gene 2012, 504:144-149.
-
(2012)
Gene
, vol.504
, pp. 144-149
-
-
Bustamante-Aragonés, A.1
-
3
-
-
0033051033
-
Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment
-
Carlson A.D., Obeid J.S., Kanellopoulou N., Wilson R.C., New M.I. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. The Journal of Steroid Biochemistry and Molecular Biology 1999, 69:19-29.
-
(1999)
The Journal of Steroid Biochemistry and Molecular Biology
, vol.69
, pp. 19-29
-
-
Carlson, A.D.1
Obeid, J.S.2
Kanellopoulou, N.3
Wilson, R.C.4
New, M.I.5
-
4
-
-
84876100471
-
Haplotype-assisted accurate non-invasive fetal whole genome recovery through maternal plasma sequencing
-
Chen S., et al. Haplotype-assisted accurate non-invasive fetal whole genome recovery through maternal plasma sequencing. Genome Medicine 2013, 5:18.
-
(2013)
Genome Medicine
, vol.5
, pp. 18
-
-
Chen, S.1
-
5
-
-
0036231537
-
Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study
-
Chiu R.W., Lau T.K., Cheung P.T., Gong Z.Q., Leung T.N., Lo Y.M. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clinical Chemistry 2002, 48:778-780.
-
(2002)
Clinical Chemistry
, vol.48
, pp. 778-780
-
-
Chiu, R.W.1
Lau, T.K.2
Cheung, P.T.3
Gong, Z.Q.4
Leung, T.N.5
Lo, Y.M.6
-
6
-
-
0037190608
-
Prenatal exclusion of beta thalassaemia major by examination of maternal plasma
-
Chiu R.W., Lau T.K., Leung T.N., Chow K.C., Chui D.H., Lo Y.M. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002, 360:998-1000.
-
(2002)
Lancet
, vol.360
, pp. 998-1000
-
-
Chiu, R.W.1
Lau, T.K.2
Leung, T.N.3
Chow, K.C.4
Chui, D.H.5
Lo, Y.M.6
-
7
-
-
84863954202
-
Non-invasive prenatal measurement of the fetal genome
-
Fan H.C., Gu W., Wang J., Blumenfeld Y.J., El-Sayed Y.Y., Quake S.R. Non-invasive prenatal measurement of the fetal genome. Nature 2012, 487:320-324.
-
(2012)
Nature
, vol.487
, pp. 320-324
-
-
Fan, H.C.1
Gu, W.2
Wang, J.3
Blumenfeld, Y.J.4
El-Sayed, Y.Y.5
Quake, S.R.6
-
8
-
-
0036797932
-
Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma
-
Gonzalez-Gonzalez M.C., et al. Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenatal Diagnosis 2002, 22:946-948.
-
(2002)
Prenatal Diagnosis
, vol.22
, pp. 946-948
-
-
Gonzalez-Gonzalez, M.C.1
-
9
-
-
18744390309
-
Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency)
-
Keen-Kim D., et al. Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency). The Journal of Molecular Diagnostics 2005, 7:236-246.
-
(2005)
The Journal of Molecular Diagnostics
, vol.7
, pp. 236-246
-
-
Keen-Kim, D.1
-
10
-
-
84862118837
-
Noninvasive whole-genome sequencing of a human fetus
-
Kitzman J.O., et al. Noninvasive whole-genome sequencing of a human fetus. Science Translational Medicine 2012, 4:137ra76.
-
(2012)
Science Translational Medicine
, vol.4
, pp. 137-276
-
-
Kitzman, J.O.1
-
11
-
-
84866977090
-
Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to β-thalassemia
-
Lam K.W., et al. Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to β-thalassemia. Clinical Chemistry 2012, 58:1467-1475.
-
(2012)
Clinical Chemistry
, vol.58
, pp. 1467-1475
-
-
Lam, K.W.1
-
12
-
-
84889080221
-
Non-invasive prenatal testing using massively parallel sequencing of maternal plasma DNA: from molecular karyotyping to fetal whole-genome sequencing
-
Lo Y.M. Non-invasive prenatal testing using massively parallel sequencing of maternal plasma DNA: from molecular karyotyping to fetal whole-genome sequencing. Reproductive Biomedicine Online 2013, 27:593-598.
-
(2013)
Reproductive Biomedicine Online
, vol.27
, pp. 593-598
-
-
Lo, Y.M.1
-
13
-
-
0342618532
-
Presence of fetal DNA in maternal plasma and serum
-
Lo Y.M., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
-
(1997)
Lancet
, vol.350
, pp. 485-487
-
-
Lo, Y.M.1
-
14
-
-
78650207098
-
Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus
-
Lo Y.M., et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Science Translational Medicine 2010, 2:61ra91.
-
(2010)
Science Translational Medicine
, vol.2
-
-
Lo, Y.M.1
-
15
-
-
58149401202
-
Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma
-
Lun F.M., et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:19920-19925.
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, pp. 19920-19925
-
-
Lun, F.M.1
-
16
-
-
77956568802
-
Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses
-
Mercè Fernández-Balsells M., et al. Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses. Clinical Endocrinology 2010, 73:436-444.
-
(2010)
Clinical Endocrinology
, vol.73
, pp. 436-444
-
-
Mercè Fernández-Balsells, M.1
-
17
-
-
79951665862
-
The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders
-
Miller W.L., Auchus R.J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocrine Reviews 2011, 32:81-151.
-
(2011)
Endocrine Reviews
, vol.32
, pp. 81-151
-
-
Miller, W.L.1
Auchus, R.J.2
-
18
-
-
34548405957
-
Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review
-
Mujezinovic F., Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstetrics and Gynecology 2007, 110:687-694.
-
(2007)
Obstetrics and Gynecology
, vol.110
, pp. 687-694
-
-
Mujezinovic, F.1
Alfirevic, Z.2
-
19
-
-
0023876992
-
Disorders of gonadal differentiation and congenital adrenalhyperplasia
-
PubMed PMID: 3042390
-
New M.I., Josso N. Disorders of gonadal differentiation and congenital adrenalhyperplasia. Endocrinol. Metab. Clin. North. Am. 1988, 17:339-366. PubMed PMID: 3042390.
-
(1988)
Endocrinol. Metab. Clin. North. Am.
, vol.17
, pp. 339-366
-
-
New, M.I.1
Josso, N.2
-
20
-
-
0031981073
-
Diagnosis and management of congenital adrenal hyperplasia
-
New M.I. Diagnosis and management of congenital adrenal hyperplasia. Annual Review of Medicine 1998, 49:311-328.
-
(1998)
Annual Review of Medicine
, vol.49
, pp. 311-328
-
-
New, M.I.1
-
21
-
-
85047686218
-
Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies
-
New M.I., et al. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. The Journal of Clinical Endocrinology and Metabolism 2001, 86:5651-5657.
-
(2001)
The Journal of Clinical Endocrinology and Metabolism
, vol.86
, pp. 5651-5657
-
-
New, M.I.1
-
22
-
-
84867013916
-
An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia
-
New M.I., Abraham M., Yuen T., Lekarev O. An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia. Seminars in Reproductive Medicine 2012, 30:396-399.
-
(2012)
Seminars in Reproductive Medicine
, vol.30
, pp. 396-399
-
-
New, M.I.1
Abraham, M.2
Yuen, T.3
Lekarev, O.4
-
23
-
-
34247499906
-
Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
-
Nimkarn S., New M.I. Prenatal diagnosis and treatment of congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Nature Clinical Practice. Endocrinology & Metabolism 2007, 3:405-413.
-
(2007)
Nature Clinical Practice. Endocrinology & Metabolism
, vol.3
, pp. 405-413
-
-
Nimkarn, S.1
New, M.I.2
-
24
-
-
77950662467
-
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a paradigm for prenatal diagnosis and treatment
-
Nimkarn S., New M.I. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a paradigm for prenatal diagnosis and treatment. Annals of the New York Academy of Sciences 2010, 1192:5-11.
-
(2010)
Annals of the New York Academy of Sciences
, vol.1192
, pp. 5-11
-
-
Nimkarn, S.1
New, M.I.2
-
25
-
-
0023903807
-
Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
-
Pang S.Y., et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988, 81:866-874.
-
(1988)
Pediatrics
, vol.81
, pp. 866-874
-
-
Pang, S.Y.1
-
26
-
-
0034818672
-
Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia
-
Rijnders R.J., van der Schoot C.E., Bossers B., de Vroede M.A., Christiaens G.C. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstetrics and Gynecology 2001, 98:374-378.
-
(2001)
Obstetrics and Gynecology
, vol.98
, pp. 374-378
-
-
Rijnders, R.J.1
van der Schoot, C.E.2
Bossers, B.3
de Vroede, M.A.4
Christiaens, G.C.5
-
28
-
-
77956588420
-
Endocrine Society: congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline
-
Speiser P.W., et al. Endocrine Society: congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism 2010, 95:4133-4160.
-
(2010)
The Journal of Clinical Endocrinology and Metabolism
, vol.95
, pp. 4133-4160
-
-
Speiser, P.W.1
-
29
-
-
0034454269
-
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
-
White P.C., Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Reviews 2000, 21:245-291.
-
(2000)
Endocrine Reviews
, vol.21
, pp. 245-291
-
-
White, P.C.1
Speiser, P.W.2
|